Vycor Medical Inc
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive co… Read more
Vycor Medical Inc (VYCO) - Total Liabilities
Latest total liabilities as of September 2025: $4.97 Million USD
Based on the latest financial reports, Vycor Medical Inc (VYCO) has total liabilities worth $4.97 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Vycor Medical Inc - Total Liabilities Trend (2012–2024)
This chart illustrates how Vycor Medical Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Vycor Medical Inc Competitors by Total Liabilities
The table below lists competitors of Vycor Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KAWASAKI HEAVY IND - Dusseldorf Stock Exchang
DU:KHE
|
Germany | €2.03 Trillion |
|
CASELLA WASTE SYS-A
BE:WA3
|
Germany | €1.59 Billion |
|
Century Global Commodities Corp
PINK:CEUMF
|
USA | $2.60 Million |
|
CREALOGIX HLDG N
MU:CX1
|
Germany | €62.33 Million |
|
PolyPlank publ AB
ST:POLY
|
Sweden | Skr21.55 Million |
|
AB Linas
MU:YCJ
|
Germany | €2.27 Million |
|
WYNN RESORTS - Dusseldorf Stock Exchang
DU:WYR
|
Germany | €15.18 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down Vycor Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 5.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vycor Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vycor Medical Inc (2012–2024)
The table below shows the annual total liabilities of Vycor Medical Inc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $4.69 Million | +8.58% |
| 2023-12-31 | $4.32 Million | +13.59% |
| 2022-12-31 | $3.80 Million | +14.13% |
| 2021-12-31 | $3.33 Million | +12.22% |
| 2020-12-31 | $2.97 Million | +21.31% |
| 2019-12-31 | $2.45 Million | +34.97% |
| 2018-12-31 | $1.81 Million | +32.50% |
| 2017-12-31 | $1.37 Million | -9.50% |
| 2016-12-31 | $1.51 Million | +72.37% |
| 2015-12-31 | $877.01K | -5.19% |
| 2014-12-31 | $925.00K | -82.97% |
| 2013-12-31 | $5.43 Million | +35.11% |
| 2012-12-31 | $4.02 Million | -- |